Home › Hereditary Sensory and Autonomic Neuropathies › California
Hereditary Sensory and Autonomic Neuropathies clinical trials in California
9 studies for Hereditary Sensory and Autonomic Neuropathies are looking for participants at sites in California.
Cities in California
Study of ACR-2316 in Specific Advanced Solid Tumors
- Precision NextGen Oncology & Research Center, Beverly Hills
- Hoag Memorial Hospital Presbyterian, Newport Beach
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06667141Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT04038502A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- University of California Davis Health, Rancho Cordova
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 10, 2026 · NCT07175038A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- USC Norris Comprehensive Cancer Center, Los Angeles
- Sansum Clinic, Santa Barbara
- Providence Medical Foundation, Santa Rosa
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT04657068First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Ellison Clinic at Saint John's, Los Angeles
- UCSF Medical Center at Mission Bay, San Francisco
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT05768139Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
- START Los Angeles, Los Angeles
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT07558733Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- Hoag Memorial Hospital Presbyterian, Newport Beach
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT06993844Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
- Lundquist Inst BioMed at Harbor, Torrance
RecruitingObservational study
Ages 1 to 100 · All sexes · Updated Apr 1, 2026 · NCT05868629Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
- UC San Diego Moores Cancer Center, La Jolla
- University of California, San Francisco (UCSF), San Francisco
RecruitingPhase 2
Ages 18 and older · Women · Updated Dec 24, 2025 · NCT06463028From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.